{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T09:14:05Z","timestamp":1720602845684},"reference-count":29,"publisher":"Center for Academic Publications Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nutr Sci Vitaminol","JNSV","Journal of Nutritional Science and Vitaminology, J Nutr Sci Vitaminol","Journal of Nutritional Science and Vitaminology"],"published-print":{"date-parts":[[2019,10,31]]},"DOI":"10.3177\/jnsv.65.430","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T22:14:44Z","timestamp":1572473684000},"page":"430-434","source":"Crossref","is-referenced-by-count":5,"title":["Antidepressant-Like Effect of \u03b2-Lactolin, a Glycine-Threonine-Tryptophan-Tyrosine Peptide"],"prefix":"10.3177","volume":"65","author":[{"given":"Yasuhisa","family":"ANO","sequence":"first","affiliation":[{"name":"Research Laboratories for Health Science & Food Technologies, Kirin Company Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"OHYA","sequence":"additional","affiliation":[{"name":"Research Laboratories for Health Science & Food Technologies, Kirin Company Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"KONDO","sequence":"additional","affiliation":[{"name":"Research Laboratories for Health Science & Food Technologies, Kirin Company Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1759","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Tanti A, Belzung C. 2010. Open questions in current models of antidepressant action. Br J Pharmacol 159: 1187-1200.","DOI":"10.1111\/j.1476-5381.2009.00585.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Eisch AJ, Petrik D. 2012. Depression and hippocampal neurogenesis: a road to remission? Science 338: 72-75.","DOI":"10.1126\/science.1222941"},{"key":"3","unstructured":"3) Papakostas GI. 2009. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 70 (Suppl 6): 16-25."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon SD, Rush AJ. 2007. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry 164: 739-752.","DOI":"10.1176\/ajp.2007.164.5.739"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Opie RS, Itsiopoulos C, Parletta N, Sanchez-Villegas A, Akbaraly TN, Ruusunen A, Jacka FN. 2017. Dietary recommendations for the prevention of depression. Nutr Neurosci 20: 161-171.","DOI":"10.1179\/1476830515Y.0000000043"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Roca M, Kohls E, Gili M, Watkins E, Owens M, Hegerl U, van Grootheest G, Bot M, Cabout M, Brouwer IA, Visser M, Penninx BW. 2016. Prevention of depression through nutritional strategies in high-risk persons: rationale and design of the MooDFOOD prevention trial. BMC Psychiatry 16: 192.","DOI":"10.1186\/s12888-016-0900-z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yamamoto Y, Mizushige T, Mori Y, Shimmura Y, Fukutomi R, Kanamoto R, Ohinata K. 2015. Antidepressant-like effect of food-derived pyroglutamyl peptides in mice. Neuropeptides 51: 25-29.","DOI":"10.1016\/j.npep.2015.04.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Mizushige T, Kanegawa N, Yamada A, Ota A, Kanamoto R, Ohinata K. 2013. Aromatic amino acid-leucine dipeptides exhibit anxiolytic-like activity in young mice. Neurosci Lett 543: 126-129.","DOI":"10.1016\/j.neulet.2013.03.043"},{"key":"9","unstructured":"9) Ano Y, Ayabe T, Ohya R, Kondo K, Kitaoka S, Furuyashiki T. 2019. Tryptophan-tyrosine dipeptide, the core sequence of beta-lactolin, improves memory by modulating the dopamine system. Nutrients 11: 348."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ano Y, Ayabe T, Kutsukake T, Ohya R, Takaichi Y, Uchida S, Yamada K, Uchida K, Takashima A, Nakayama H. 2018. Novel lactopeptides in fermented dairy products improve memory function and cognitive decline. Neurobiol Aging 72: 23-31.","DOI":"10.1016\/j.neurobiolaging.2018.07.016"},{"key":"11","unstructured":"11) Cui Y, Huang C, Momma H, Ren Z, Sugiyama S, Guan L, Niu K, Nagatomi R. 2017. Consumption of low-fat dairy, but not whole-fat dairy, is inversely associated with depressive symptoms in Japanese adults. Social Psychiatry Psychiatr Epidemiol 52: 847-853."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Miyake Y, Tanaka K, Okubo H, Sasaki S, Arakawa M. 2015. Intake of dairy products and calcium and prevalence of depressive symptoms during pregnancy in Japan: a cross-sectional study. BJOG Int J Obstet Gynaecol 122: 336-343.","DOI":"10.1111\/1471-0528.12972"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Belujon P, Grace AA. 2017. Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol 20: 1036-1046.","DOI":"10.1093\/ijnp\/pyx056"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Meyer JH, Kruger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, Minifie C, Houle S, Hussey D, Kennedy SH. 2001. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12: 4121-4125.","DOI":"10.1097\/00001756-200112210-00052"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kram ML, Kramer GL, Ronan PJ, Steciuk M, Petty F. 2002. Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog Neuropsychopharmacol Biol Psychiatry 26: 639-645.","DOI":"10.1016\/S0278-5846(01)00222-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kita M, Kobayashi K, Obara K, Koikeda T, Umeda S, Ano Y. 2019. Supplementation with whey peptide rich in \u03b2-lactolin improves cognitive performance in healthy older adults: a randomized, double-blind, placebo-controlled study. Front Neurosci 13: 399.","DOI":"10.3389\/fnins.2019.00399"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD. 2012. The tail suspension test. J Vis Exp (59): 3769.","DOI":"10.3791\/3769"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Fukuda T, Ohya R, Kobayashi K, Ano Y. 2019. Matured hop bitter acids in beer improve lipopolysaccharide-induced depression-like behavior. Front Neurosci 13: 41.","DOI":"10.3389\/fnins.2019.00041"},{"key":"19","unstructured":"19) Ano Y, Hoshi A, Ayabe T, Ohya R, Uchida S, Yamada K, Kondo K, Kitaoka S, Furuyashiki T. 2019. Iso-alpha-acids, the bitter components of beer, improve hippocampus-dependent memory through vagus nerve activation. FASEB J 33: 4987-4995."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, Brown SM, Ryan ND, Birmaher B, Axelson DA, Dahl RE. 2009. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 166: 64-73.","DOI":"10.1176\/appi.ajp.2008.07081336"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S. 2006. Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res 147: 243-248.","DOI":"10.1016\/j.pscychresns.2006.03.001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Gordon I, Weizman R, Rehavi M. 1996. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter. Eur J Pharmacol 298: 27-30.","DOI":"10.1016\/0014-2999(95)00770-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Binfare RW, Mantovani M, Budni J, Santos AR, Rodrigues AL. 2010. Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test. Eur J Pharmacol 638: 78-83.","DOI":"10.1016\/j.ejphar.2010.04.011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Tanda G, Carboni E, Frau R, Di Chiara G. 1994. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115: 285-288.","DOI":"10.1007\/BF02244785"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Finberg JP, Rabey JM. 2016. Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol 7: 340.","DOI":"10.3389\/fphar.2016.00340"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Weinreb O, Badinter F, Amit T, Bar-Am O, Youdim MB. 2015. Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged mice. Neurobiol Aging 36: 2628-2636.","DOI":"10.1016\/j.neurobiolaging.2015.05.009"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Korchounov A, Winter Y, Rossy W. 2012. Combined beneficial effect of rasagiline on motor function and depression in de novo PD. Clin Neuropharmacol 35: 121-124.","DOI":"10.1097\/WNF.0b013e31823b1da8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Reagan-Shaw S, Nihal M, Ahmad N. 2008. Dose translation from animal to human studies revisited. FASEB J 22: 659-661.","DOI":"10.1096\/fj.07-9574LSF"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nair AB, Jacob S. 2016. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7: 27-31.","DOI":"10.4103\/0976-0105.177703"}],"container-title":["Journal of Nutritional Science and Vitaminology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/65\/5\/65_430\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T03:50:09Z","timestamp":1572666609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/65\/5\/65_430\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.3177\/jnsv.65.430","relation":{},"ISSN":["0301-4800","1881-7742"],"issn-type":[{"value":"0301-4800","type":"print"},{"value":"1881-7742","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]}}}